Fulzerasib
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or Without Resectable Metastases (NCT07581912) | Zhejiang University | 2026-04-30 |
Track Fulzerasib automatically
Every clearance here is in the API, with alerts when new ones post.